Morgan Stanley’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-504
| Closed | -$5.73K | – | 8137 |
|
|
2023
Q4 | $5.73K | Buy |
504
+33
| +7% | +$375 | ﹤0.01% | 6976 |
|
|
2023
Q3 | $1.9K | Sell |
471
-102
| -18% | -$411 | ﹤0.01% | 7145 |
|
|
2023
Q2 | $4.07K | Buy |
573
+201
| +54% | +$1.43K | ﹤0.01% | 7033 |
|
|
2023
Q1 | $2.77K | Buy |
372
+78
| +27% | +$581 | ﹤0.01% | 7179 |
|
|
2022
Q4 | $2.13K | Sell |
294
-1,102
| -79% | -$8K | ﹤0.01% | 7357 |
|
|
2022
Q3 | $14K | Sell |
1,396
-1,787
| -56% | -$17.9K | ﹤0.01% | 6962 |
|
|
2022
Q2 | $60K | Buy |
3,183
+1,288
| +68% | +$24.3K | ﹤0.01% | 6531 |
|
|
2022
Q1 | $94K | Buy |
1,895
+612
| +48% | +$30.4K | ﹤0.01% | 6355 |
|
|
2021
Q4 | $97K | Sell |
1,283
-6,093
| -83% | -$461K | ﹤0.01% | 6459 |
|
|
2021
Q3 | $583K | Sell |
7,376
-13,923
| -65% | -$1.1M | ﹤0.01% | 5399 |
|
|
2021
Q2 | $2.96M | Buy |
21,299
+21,134
| +12,808% | +$2.93M | ﹤0.01% | 4309 |
|
|
2021
Q1 | $34K | Sell |
165
-1,246
| -88% | -$257K | ﹤0.01% | 6535 |
|
|
2020
Q4 | $234K | Buy |
1,411
+1,151
| +443% | +$191K | ﹤0.01% | 5515 |
|
|
2020
Q3 | $44K | Sell |
260
-1,684
| -87% | -$285K | ﹤0.01% | 5762 |
|
|
2020
Q2 | $323K | Buy |
1,944
+599
| +45% | +$99.5K | ﹤0.01% | 4832 |
|
|
2020
Q1 | $156K | Sell |
1,345
-700
| -34% | -$81.2K | ﹤0.01% | 4979 |
|
|
2019
Q4 | $303K | Buy |
2,045
+1,412
| +223% | +$209K | ﹤0.01% | 5212 |
|
|
2019
Q3 | $86K | Buy |
633
+552
| +681% | +$75K | ﹤0.01% | 5495 |
|
|
2019
Q2 | $10K | Buy |
81
+27
| +50% | +$3.33K | ﹤0.01% | 6142 |
|
|
2019
Q1 | $5K | Buy |
+54
| New | +$5K | ﹤0.01% | 6336 |
|